Just looking into this a bit more today. Although I'm happy for the progress, I hope Bader has some tricks up his sleeve promising break-even FY18.
Revenue growth rates of the recent quarters have been (most recent first) 8%, 6%, 14%, 10%. So average at 9.5%. If we apply that growth rate going forward we get:
514,000 revenue Q1
563,000 revenue Q2
616,485 revenue Q3
674,520 revenue Q4
Total FY revenue estimated at 2.37m (roughly)
Expenses FY looking like (assuming it remains the same):
1,278,000 expenses Q1 (based on underlying numbers)
1,278,000 expenses Q2 (based on underlying numbers)
1,278,000 expenses Q3 (based on underlying numbers)
1,278,000 expenses Q4 (based on underlying numbers)
EBITDA (underlying)
Q1 = (764)
Q2 = (715)
Q3 = (662)
Q4 = (604)
FY = (2,745,000) FY17 was -5,822,000 so it's still a large improvement.
Based on extrapolating last reported period with previous period's average growth results, break-even FY isn't looking probable with what we currently know. In order to get there we need either greater than 9.5% PCP growth in revenue (I haven't calculated it out - but probably closer to 15/20) and/or expenses going down significantly.
- Forums
- ASX - By Stock
- RNT
- Finally closes above 200MA
Finally closes above 200MA, page-11
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.35M |
Open | High | Low | Value | Volume |
2.3¢ | 2.3¢ | 2.2¢ | $8.907K | 390.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 262647 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 173262 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 327598 | 0.017 |
3 | 139228 | 0.016 |
9 | 948115 | 0.015 |
3 | 445000 | 0.014 |
3 | 191615 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 345544 | 1 |
0.019 | 168070 | 4 |
0.020 | 2702 | 1 |
0.021 | 382000 | 3 |
0.022 | 18333 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
RNT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online